Atopic Dermatitis in Children and Adults Diagnosis and Treatment

Keyphrases

• Atopic Dermatitis 100%
• Anti-inflammatory Therapy 66%
• Patient-specific 33%
• Disease Course 33%
• PubMed 33%
• Severe Disease 33%
• Recurring 33%
• Severe Cases 33%
• Patient Education 33%
• Allergen 33%
• Trigger Factor 33%
• Systemic Therapy 33%
• Biological Agents 33%
• German Guidelines 33%
• Barrier Function 33%
• Dupilumab 33%
• Skin Irritation 33%
• Interdisciplinary Treatment 33%
• Baricitinib 33%
• Abrocitinib 33%
• Topical Agents 33%
• Social Medicine 33%
• Microbial Pathogens 33%
• European Guidelines 33%
• External Treatment 33%
• Long-course 33%
• Topical Calcineurin Inhibitors 33%
• Proactive Therapy 33%
• Topical Glucocorticosteroids 33%
• Baseline Therapy 33%
• Tralokinumab 33%
• Immunosuppressant Drugs 33%
• Selective Search 33%
• Inflammatory Skin Diseases 33%
• Disease Burden 33%
• Janus Kinase Inhibitors 33%
• Basic Treatment 33%
• Upadacitinib 33%
• Drug-free 33%
• Cutaneous Findings 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Atopic Dermatitis 100%
• Anti-Inflammatory Drug 66%
• Diseases 66%
• Infectious Agent 33%
• Topical Agent 33%
• Immunosuppressive Agent 33%
• Glucocorticoid 33%
• Recurrent Disease 33%
• Dermatitis 33%
• Calcineurin Inhibitor 33%
• Irritant Agent 33%
• Biological Product 33%
• Dupilumab 33%
• Upadacitinib 33%
• Baricitinib 33%
• Tralokinumab 33%
• Allergen 33%
• Janus Kinase Inhibitor 33%